The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ...

Rheumatologists report largely adhering to American College of Rheumatology guidelines for gout management, but show notable ...

Objective In 2011, the American College of Rheumatology (ACR) and EULAR endorsed provisional criteria for remission in rheumatoid arthritis (RA), both Boolean-based and index-based. Based on recent ...

While you wait for the groundhog to make his determination this weekend, take some time to buff up your knowledge of rheumatoid arthritis, a chronic autoimmune disease that affects about 1.5 million ...

The 2024 American College of Rheumatology (ACR) annual meeting spotlighted transformative advancements in cell therapies for autoimmune diseases, with chimeric antigen receptor (CAR)-T therapies ...

Acrivon Therapeutics said the Food and Drug Administration has granted Breakthrough Device designation for its ACR-368 OncoSignature assay, an immunofluorescence assay for the identification of ...

Objective To assess agreement between 1987 American College of Rheumatology (ACR) and 2010 ACR/European League Against Rheumatism (EULAR) criteria and the potential source of discordance, based on ...

AIM = Abatacept in Inadequate responders to Methotrexate; ATTAIN = Abatacept Trial in Treatment of Anti-TNF Inadequate responders; ACR = American College of Rheumatology; DAS28 = Disease Activity ...

Specifically, patients receiving the combination therapy showed higher rates of improvement in the American College of Rheumatology (ACR) response criteria (ACR20, ACR50, and ACR70) and a ...

The 2019 EULAR/ACR systemic lupus erythematosus classification criteria were not predictive of mortality or hospitalization. While the 2019 European Alliance of Associations for Rheumatology ...

Tedeschi SK, Frits M, Cui J, et al. Diet and rheumatoid arthritis symptoms: Survey results from a rheumatoid arthritis registry. Arthritis Care Res (Hoboken). 2017;69(12):1920-1925.

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...